COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT06380075
- Status
- Recruiting
Conditions
- Retinal Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spectralis FAF imaging — DEVICESpectralis is a scanning laser ophthalmoscope which uses a blue light excitation wavelength of 488nm and a 500nm barrier filter to produce FAF images. Spectralis images 20-55 degrees of the retina.
- Optos imaging — DEVICEOptos is an ultrawide field imaging platform which images up to 200 degrees of the retina. It uses both a green-light excitation wavelength of 532nm and a red-light excitation wavelength of 633nm with an emission filter of greater than 540nm to produce FAF images.
- Clarus imaging — DEVICEClarus 700 is an ultrawide field imaging system with similar retinal coverage to that of Optos. It uses Broad Line Fundus Imaging to produce blue FAF images at excitation wavelengths of 435-500nm and green FAF images at wavelengths of 500-585nm
Study Details
The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs). Participants will: * undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras
Key Dates
- Start date
- Aug 29, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Fundus autofluorescence (FAF) imaging
Primary Outcome Measure
Compare FAF retinal patterns by Clarus and standard Spectralis FAF imaging [ Time Frame: Up to 2 hours ]
Central Contacts
- Angie Adler608-265-7557
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Department of Ophthalmology and Visual Sciences | Madison | Wisconsin | 53705 | Kimberly Stepien, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Madison, WI
By research site
Related Studies
- Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A GenePHASE2 · Recruiting · Laboratoires Thea · San Francisco, California
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 GeneRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Cell Collection to Study Eye DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland